MOD 4 ASSNG
euro1776
MOD4ASSIGNMENTPROMPT.docx· Due Jul 19 by 10:59pm
· Points 100
· Submitting a text entry box or a file upload
· Attempts 0
· Allowed Attempts 2
Back to Module 4: Psychopharmacology of Psychosis and Mood Disorders
Mood Stabilizers Narrated Presentation
Mood stabilizers are a cornerstone in the treatment of bipolar and related mood disorders, requiring careful consideration of neurobiology, pharmacologic mechanisms, and patientspecific factors. For the psychiatricmental health nurse practitioner (PMHNP), selecting and managing these medications involves balancing efficacy with safety, tolerability, and longterm outcomes across diverse clinical presentations.
This assignment will give you an opportunity to discuss the four traditional mood stabilizer medications and their implications of use for patients with a variety of factors, including special population considerations, FDA approval indications, and drug-to-drug interactions. You will consult evidence-based, scholarly sources to support your presentation.
Level 2: AI for Study and Planning Support
· AI use is required and is to be used for brainstorming, outlining, or studying
· You are fully responsible for the final work
Resources
Be sure to review the Learning Resources before completing this assessment.
To prepare:
· Review the Required Learning Resources.
· Review indications and considerations for traditional mood stabilizer psychopharmacology treatments, including carbamazepine, lamotrigine, lithium, and valproate products.
The Assignment
Construct a 5- to 6-slide PowerPoint presentation with Voiceover narration discussing each of the four traditional mood stabilizer medications: carbamazepine, lamotrigine, lithium, and valproate products. Support your answers with five (5) evidence-based, peer-reviewed scholarly literature.
Note: APA style format will apply.
Your PowerPoint slide presentation with Voiceover narration should include the following for each:
· Proposed mechanism of action
· Baseline assessment, laboratory considerations, and frequency of ongoing labs and assessments
Note: Discuss the importance of assessment and labs.
· Special population considerations (birth assigned gender, age, other medical comorbidity considerations)
· FDA approval indications
· Typical dosing with discussion on therapeutic endpoints for psychiatric use
· Major drug–drug interaction considerations
· For each of these medications, please review potential drug–drug interactions listed below. Consider alternative dosing schedules, clinical implications for the drug interactions, additional patient education needed, any additional monitoring recommended, or collaboration needed with other medical professions (such as, primary care providers)
· Lamotrigine + Valproate
· Lamotrigine + Rifampin
· Valproate + Estrogen containing birth control
· Valproate + Amitriptyline
· Lithium + Furosemide
· Lithium + Lisinopril
· Carbamazepine + Lurasidone
· Carbamazepine + Grapefruit juice
· Discuss the ethical, legal, and social implications related to prescribing bipolar and other related mood-disorder diagnoses therapy for patients.
By Sunday of Week 8
Submit by Sunday of Week 8. You must also submit a completed AI Assessment Template document, found in this Assessment's Learning Resources.
Submission Information
Before submitting your final assignment, you can check your draft for authenticity. To check your draft, access the Turnitin Drafts from the Start Here area.
1. To submit your completed assignment, save your PowerPoint slide presentation with Voiceover narration Assignment as MD4AssgnPT1_LastName_FirstInitial. Save your AI Assessment as MD4AssgnPT2_LastName_FirstInitial.
2. Then, click on Start Assignment near the top of the page.
3. Next, click on Upload File and select your PowerPoint slide presentation with Voiceover narration.
4. Next, click on the + Add Another File button and upload your AI Assessment.
5. Finally, click on Submit Assignment for review.
Rubric
NURS_6630_Module4_Assignment _Rubric
|
NURS_6630_Module4_Assignment _Rubric |
||
|
Criteria |
Ratings |
Pts |
|
This criterion is linked to a Learning OutcomePowerPoint presentation discusses each of the four traditional mood stabilizer medications: carbamazepine, lamotrigine, lithium, and valproate and a proposed mechanism of action for each as well as baseline assessments, laboratory considerations, and the frequency of ongoing labs and assessments. |
20 to >17.88 ptsExcellentProvides a fully developed discussion of the four traditional mood stabilizer medications, a proposed action for each, and baseline assessments, laboratory consideration, and the frequency of ongoing labs and assessments. 17.88 to >15.88 ptsGoodProvides an adequately developed discussion of the four traditional mood stabilizer medications, a proposed action for each, and baseline assessments, laboratory consideration, and the frequency of ongoing labs and assessments. 15.88 to >13.88 ptsFairProvides a minimally developed discussion of the four traditional mood stabilizer medications, a proposed action for each, and baseline assessments, laboratory consideration, and the frequency of ongoing labs and assessments. 13.88 to >0 ptsPoorDoes not provide a discussion of each of the four traditional mood stabilizer medications, a proposed action for each, and baseline assessments, laboratory consideration, and the frequency of ongoing labs and assessments. |
20 pts |
|
This criterion is linked to a Learning OutcomeDrug-Drug interaction, dosing schedules, and clinical implications for the drug interactions are considered and any additional patient education, recommended monitoring, and collaboration with other medical professionals are noted. |
10 to >8.94 ptsExcellentProvides a fully developed analysis of drug interactions, dosing schedules, and clinical implications, along with patient consideration and recommendations for monitoring and collaboration with other medical professionals. 8.94 to >7.94 ptsGoodProvides an adequately developed analysis of drug interactions, dosing schedules, and clinical implications, along with patient consideration and recommendations for monitoring and collaboration with other medical professionals. 7.94 to >6.94 ptsFairProvides a minimally developed analysis of drug interactions, dosing schedules, and clinical implications, along with patient consideration and recommendations for monitoring and collaboration with other medical professionals. 6.94 to >0 ptsPoorDoes not provide an analysis of drug interactions, dosing schedules, and clinical implications, along with patient consideration and recommendations for monitoring and collaboration with other medical professionals. |
10 pts |
|
This criterion is linked to a Learning OutcomeThe presentation discusses the ethical, legal, and social implications related to prescribing bipolar and other related mood-disorder diagnoses therapy for patients. |
10 to >8.94 ptsExcellentProvides a fully developed discussion of the ethical, legal, and social implications related to prescribing bipolar and other related mood-disorder diagnoses therapy. 8.94 to >7.94 ptsGoodProvides an adequately developed discussion of the ethical, legal, and social implications related to prescribing bipolar and other related mood-disorder diagnoses therapy. 7.94 to >6.94 ptsFairProvides a minimally developed discussion of the ethical, legal, and social implications related to prescribing bipolar and other related mood-disorder diagnoses therapy. 6.94 to >0 ptsPoorDoes not provide a discussion of the ethical, legal, and social implications related to prescribing bipolar and other related mood-disorder diagnoses therapy for patients. |
10 pts |
|
This criterion is linked to a Learning OutcomeThe presentation is supported by five (5) evidence-based, peer reviewed scholarly articles. |
10 to >8.94 ptsExcellentUses 5 evidence-based, peer-reviewed articles. 8.94 to >7.94 ptsGoodUses 3 evidence-based, peer-reviewed articles. 7.94 to >6.94 ptsFairUses 1 evidence-based, peer-reviewed article. 6.94 to >0 ptsPoorDoes not use evidence-based, peer-reviewed articles. |
10 pts |
|
This criterion is linked to a Learning OutcomeProfessionalism and Design |
15 to >13.41 ptsExcellentPresentation is consistently professional, well designed, and easy to follow... Visuals consistently complement the content. 13.41 to >11.91 ptsGoodPresentation is mostly professional, well designed, and easy to follow... Visuals mostly complement the content. 11.91 to >10.41 ptsFairPresentation is minimally professional. Some parts are poorly designed and difficult to follow... Visuals are poorly designed and/or do not complement content in some sections. 10.41 to >0 ptsPoorPresentation is disorganized, unclear, or incomplete... Visuals are distracting, confusing, or do not complement the content. |
15 pts |
|
This criterion is linked to a Learning OutcomeSpeaker Delivery in Voiceover Narration |
15 to >13.41 ptsExcellentSpeaker delivery is consistently engaging and clear. 13.41 to >11.91 ptsGoodSpeaker delivery is mostly engaging and clear. 11.91 to >10.41 ptsFairSpeaker delivery is minimally engaging. Some sections lack clarity. 10.41 to >0 ptsPoorSpeaker delivery is unclear or incomplete. |
15 pts |
|
This criterion is linked to a Learning OutcomeSource Attribution and APA Formatting |
10 to >8.94 ptsExcellentAll sources are cited in APA format without any errors... All images from sources include proper attribution without APA formatting errors. 8.94 to >7.94 ptsGoodAll sources are cited in APA format with some minor errors... All images from sources include proper attribution with minor APA formatting errors. 7.94 to >6.94 ptsFairAll sources are cited with frequent APA formatting errors... All images from sources include improper attribution with frequent APA formatting errors 6.94 to >0 ptsPoorExcludes source citations or shows minimal adherence to APA formatting rules... All images from sources lack attribution. |
10 pts |
|
This criterion is linked to a Learning OutcomeGrammar, Mechanics, and Punctuation |
10 to >8.94 ptsExcellentUses correct grammar, spelling, and punctuation with no errors. 8.94 to >7.94 ptsGoodUses correct grammar, spelling, and punctuation with few errors. 7.94 to >6.94 ptsFairUses correct grammar, spelling, and punctuation with frequent errors. 6.94 to >0 ptsPoorPost contains frequent errors in grammar, spelling, and punctuation that interfere with comprehension. |
10 pts |
Total Points: 100
RESOURCES
Be sure to review the Learning Resources before completing this assessment.
· Stahl, S. M. (2021). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press.
· Chapter 6, "Mood Disorders and the Neurotransmitter Networks Norepinephrine and y-Aminobutyric Acid (GABA)" (pp. 2442–82)
· American Psychiatric Association. (2010). Practice guideline for the treatment of patients with bipolar disorderLinks to an external site. (2nd ed.). APA. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/bipolar.pdf
· Drugs.comLinks to an external site. . (2023). https://www.drugs.com/ Note: Please use the following resource to check the most up-to-date box warnings, FDA approvals and indications, recommendations for follow-up evaluations, changes, etc.
· Approved Medications for Bipolar and Related Mood Disorders Note: Utilize the following medication table to familiarize yourself with the medications aligned with the topics presented this week.
|
Approved Medications for Bipolar and Related Mood Disorders |
|||
|
Chlorpromazine |
Fluphenazine |
Haloperidol |
Loxapine |
|
Perphenazine |
Aripiprazole |
Asenapine |
Clozapine |
|
Iloperidone |
Olanzapine |
Paliperidone |
Quetiapine |
|
Risperidone |
Ziprasidone |
Lurasidone |
Brexpiprazole |
|
Cariprazine |
Lumateperone |
Benztropine |
Propranolol |
|
Deutetrabenazine |
Valbenazine |
|
|
· NEI Psychopharm. (2022, March 15). What is a mood stabilizerLinks to an external site. [Video]. YouTube. https://www.youtube.com/watch?v=wXzGIkJ-h5I&list=PLYAIFzMMgrFpTVhVqfIyB9tPLT43Ec7In&index=6
· NEI Psychopharm. (2022, March 15). Lithium's mechanism of actionLinks to an external site. [Video]. YouTube. https://www.youtube.com/watch?v=8EtcNggYb2s&list=PLYAIFzMMgrFpTVhVqfIyB9tPLT43Ec7In&index=7
· In your NEI membership: Under the Membership tab click Stahl’s Essential Psychopharmacology Video Edition. Click the Stahl’s Essential Video for CME/CE. Complete Chapter 6.
· Document: AI Assessment Template (Word)Links to an external site.
